Regional Differences and Metabolic Changes in Normal Aging of the Human Brain: Proton MR Spectroscopic Imaging Study

References

1. ↵
   Von Dras DD, Blumenthal HT. Dementia of the aged: disease or atypical-accelerated aging? biopathological and psychological perspectives. J Am Geriatr Soc 1992;40:285-294

   PubMedWeb of Science
2. ↵
   Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol 1997;56:1269-1275

   PubMedWeb of Science
3. ↵
   Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol 1987;21:530-539

   CrossRefPubMedWeb of Science
4. ↵
   Hatanpaa K, Isaacs KR, Shirao T, Brady DR, Rapoport SI. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J Neuropathol Exp Neurol 1999;58:637-643

   CrossRefPubMedWeb of Science
5. ↵
   Double KL, Halliday GM, Kril JJ, et al. Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol Aging 1996;17:513-521

   CrossRefPubMedWeb of Science
6. Raz N, Gunning FM, Head D, et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cerebral Cortex 1997;7:268-282

   Abstract/FREE Full Text
7. Lim KO, Zipursky RB, Watts MC, Pfefferbaum A. Decreased gray matter in normal aging: an in vivo magnetic resonance study. J Gerontol 1992;47:b26-b30
8. Guttmann CRG, Killiany RJ, Moss MB, Sandor T, Albert MS, Jolesz FA. White matter changes with normal aging. Neurobiology 1998;50:972-978
9. ↵
   Almkvist O, Wahlund L-O, Andersson-Lundman G, Basun H, Backman J. White matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49:626-632

   CrossRefPubMedWeb of Science
10. Rao SM, Mittenberg W, Bernardin L, Haughton V, Leo GJ. Neurological test findings in subjects with leukoariosis. Arch Neurol 1997;49:40-44
11. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age. Brain 1990;113:27-47

    Abstract/FREE Full Text
12. Meyer JS, Terayama Y, Takashima S. Cerebral circulation in the elderly. Cereb Brain Metab Rev 1993;5:122-146

    PubMedWeb of Science
13. Pantano P, Baron J-C, Lebrun-Grandié P, Duquesnoy N, Bousser M-G, Comar D. Regional cerebral blood flow oxygen consumption in human aging. Stroke 1984;15:635-641

    Abstract/FREE Full Text
14. ↵
    Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 1995;36:1141-1149

    Abstract/FREE Full Text
15. ↵
    Christiansen P, Toft P, Larsson HBW, Stubgaard M, Henriksen O. The concentration of N-acetyl aspartate, creatine + phophocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging 1993;11:799-806

    CrossRefPubMedWeb of Science
16. Fukuzako H, Hashiguchi T, Sakamoto Y, et al. Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects. Psychiatry Clin Neurosci 1997;51:261-263

    PubMed
17. ↵
    Chang L, Ernst T, Poland RE, Jenden DJ. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci 1996;58:2049-2056

    CrossRefPubMedWeb of Science
18. Charles CH, Lazeyras F, Krishnan KRR, et al. Proton spectroscopy of human brain: effects of age and sex. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:995-1004

    CrossRefPubMed
19. ↵
    Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Aging of the adult human brain: in vivo quantification of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imaging 1999;9:711-716

    CrossRefPubMedWeb of Science
20. ↵
    Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994;44:1411-1417

    Abstract/FREE Full Text
21. ↵
    Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323-325

    CrossRefPubMedWeb of Science
22. Graham GD, Blamire AM, Rothman DL, et al. Early temporal variation of cerebral metabolites after human stroke: a proton magnetic resonance spectroscopy study. Stroke 1993;24:1891-1896

    Abstract/FREE Full Text
23. Kwo-On-Yuen PF, Newmark RD, Budinger TF, Kaye JA, Ball MJ, Jagust WJ. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study. Brain Res 1994;667:167-174

    CrossRefPubMedWeb of Science
24. ↵
    Urenjak J, Williams RJ, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989

    Abstract
25. ↵
    Lim KO, Spielman DM. Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn Reson Med 1997;37:372-377

    PubMedWeb of Science
26. ↵
    DeStefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121:1469-1477

    Abstract/FREE Full Text
27. ↵
    Longo R, Ricci C, Dalla Palma L, et al. Quantitative 31P MRS of the normal adult human brain: assessment of interindividual differences and ageing effects. NMR Biomed 1993;6:53-57

    PubMedWeb of Science
28. Soher BJ, Van Zijl PCM, Duyn JH, Barker PB. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996;35:356-363

    PubMedWeb of Science
29. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med 1999;41:276-284

    CrossRefPubMedWeb of Science
30. Lundbom N, Barnett A, Bonavita S, et al. MR image segmentation and tissue metabolite contrast in ¹H spectroscopic imaging of normal and aging brain. Magn Reson Med 1999;41:841-845

    CrossRefPubMedWeb of Science
31. Tedeschi G, Bertolino A, Righini A, et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995;45:1384-1391

    Abstract/FREE Full Text
32. Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998;39:53-60

    PubMedWeb of Science
33. ↵
    Frahm J, Bruhn H, Gyngell ML, Merbolt KD, Hänicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo: relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11:47-63

    PubMedWeb of Science
34. ↵
    Folstein MF, Folstein SE, McHugh PR. Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198

    CrossRefPubMedWeb of Science
35. ↵
    Patt SL, Sykes BD. T1 water eliminated Fourier transform NMR spectroscopy. J Chem Phys 1972;55:3182-3184
36. ↵
    Den Hollander JA, Oosterwaal B, Van Vroonhoven H, Luyten PR. Elimination of magnetic field distortions in ¹H NMR spectroscopic imaging. Presented at the Annual Meeting of the Society of Magnetic Resonance in Medicine, San Francisco, August 1991
37. ↵
    Roth K, Kimber BJ, Feeney J. Data shift accumulation and alternate delay accumulation techniques for overcoming dynamic range problems. J Magn Reson 1980;41:302-304

    Web of Science
38. ↵
    Tou JT, Gonzalez RC. Pattern Recognition Principles.. Reading, Ma: Addison-Wesley 1974;
39. ↵
    Hugg JW, Laxer KD, Matson GB, et al. Neuronal loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1993;34:788-794

    CrossRefPubMedWeb of Science
40. Breiter SN, Arroyo S, Mathews VP, Lesser RP, Bryan RN, Barker PB. Proton MR spectroscopy in patients with seizure disorder. AJNR Am J Neuroradiol 1994;15:373-384

    Abstract/FREE Full Text
41. ↵
    Choi CG, Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med 1999;41:204-207

    CrossRefPubMed
42. ↵
    Arnold SE, Trojanowski JQ. Human fetal hippocampal development: I. cytoarchitecture, myeloarchitecture, and neuronal morphologic features. J Comp Neurol 1996;376:274-292
43. Doyle TJ, Bedell BJ, Narayama PA. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain. Magn Reson Med 1995;33:755-759

    PubMedWeb of Science
44. Wang Y, Li SJ. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo ¹H magnetic resonance spectroscopy. Magn Reson Med 1998;39:28-33

    PubMedWeb of Science
45. Duc CO, Weber OM, Trabesinger AH, Meier D, Boesiger P. Quantitative ¹H MRS of the human brain in vivo based on the simulation phantom calibration strategy. Magn Reson Med 1998;39:491-496

    PubMedWeb of Science
46. Pan JW, Twieg DB, Hetherington HP. Quantitative spectroscopic imaging of the human brain. Magn Reson Med 1998;40:363-369

    PubMedWeb of Science
47. Hetherington HP, Mason GF, Pan JW, et al. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med 1994;32:565-571

    PubMedWeb of Science
48. Sappey-Marinier D, Calabrese G, Hetherington HP, et al. Proton magnetic resonance spectroscopy of human brain: application to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn Reson Med 1991;26:313-327

    CrossRef
49. Meyerhoff DJ, Mac Kay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994;36:40-47

    CrossRefPubMedWeb of Science
50. ↵
    Fulham MJ, Dietz MJ, Duyn JH. Transsynaptic reduction in N-acetylaspartate in cerebellar diaschisis: a proton MR spectroscopic imaging study. J Comput Assist Tomogr 1994;18:697-704

    PubMedWeb of Science
51. ↵
    Moffset JR, Namboori MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:131-134

    PubMedWeb of Science
52. Miller B. A review of chemical issues in ¹H NMR spectroscopy: N-Acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52

    PubMedWeb of Science
53. ↵
    Taylor DL, Davies SE, Obrenovitch TP, et al. Investigation into the role of N-acetylaspartate in cerebral osmoregulation. J Neurochem 1995;65:275-281

    PubMedWeb of Science
54. Vion-Dury J, Confort-Gouny S, Nicoli F, et al. Localized brain proton MRS metabolic patterns in HIV-related encephalopathies. C R Acad Sci III 1994;317:833-840

    PubMed
55. ↵
    Simic G, Kostovic I, Winblad B, Bogdanovic N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol 1997;379:482-494

    CrossRefPubMedWeb of Science
56. Matsumae M, Kikinis R, Morocz I, et al. Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance. J Neurosurg 1996;84:982-991

    PubMedWeb of Science
57. Kreis R, Ernst T, Ross BD. Development of human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437

    CrossRefPubMedWeb of Science
58. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Imag 1994;32:110-115
59. ↵
    Rouser G, Yamamoto A. Curvilinear regression course of human brain lipid composition changes with age. Lipids 1998;3:284-287
60. ↵
    Giusto NM, Roque ME, Ilincheta de Bochero MG. Effect of aging on the content, composition and synthesis of sphingomyelin in the central nervous system. Lipids 1992;27:835-839

    CrossRefPubMedWeb of Science
61. ↵
    Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in ¹H-NMR spectroscopic studies of brain. Neuro Behav Rev 1989;13:23-31
62. ↵
    Wiedermann D, Schuff N, Matson G, Soher B, Maudsley AA, Weiner MW. Test-reliability of short multislice ¹H MRSI. Presented at the Annual Meeting of the International Society for Magnetic Resonance in Medicine, Denver, April 2000
63. ↵
    Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. Age-decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging 1995;16:591-606

    CrossRefPubMedWeb of Science
64. Constans JM, Meyerhoff DJ, Gerson J, et al. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology 1995;197:517-523

    PubMedWeb of Science
65. ↵
    Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. Neurology 1997;49:1513-1521

    Abstract/FREE Full Text